At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs Ticagrelor in Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention; TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI
In Brief
A Phase 4 clinical trial evaluating Aspirin+Ticagrelor and Aspirin+Clopidogrel for Acute Myocardial Infarction. Completed, enrolled 2,590 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy and safety of clopidogrel in stabilized patients with acute myocardial infarction (AMI) who performed percutaneous coronary intervention (PCI) with drug-eluting stents (DES) compared with ticagrelor. In this study, 2,590 patients with AMI who underwent PCI with DES and took dual antiplatelet therapy as aspirin and ticagrelor during 1 month from index PCI will be randomized to aspirin+ticagrelor versus aspirin+ clopidogrel during 11 months.
Study Details
Timeline
Interventions
Aspirin+ Ticagrelor after 1month of standard DAPT (Aspirin+Ticagrelor)
Aspirin+ Clopidogrel after 1month of standard DAPT (Aspirin+Ticagrelor)